SSX2 Antikörper (C-Term)

Produktnummer ABIN927674

Produktdetails anti-SSX2 Antikörper

Target: SSX2 (Synovial Sarcoma, X Breakpoint 2 (SSX2))

Bindungsspezifität: C-Term

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser SSX2 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Aufreinigung: Purified

Immunogen: SSX2 antibody was raised in rabbit using the C terminal of SSX2 as the immunogen

Anwendungsinformationen

Applikationshinweise: WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator.

Kommentare:

SSX2 Blocking Peptide, catalog no. 33R-3849, is also available for use as a blocking control in assays to test for specificity of this SSX2 antibody

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Konzentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Handhabung: Avoid repeated freeze/thaw cycles.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Details zu SSX2

Target: SSX2 (Synovial Sarcoma, X Breakpoint 2 (SSX2))

Andere Bezeichnung: SSX2 (SSX2 Produkte)

Synonyme: CT5.2 antikoerper, CT5.2A antikoerper, HD21 antikoerper, HOM-MEL-40 antikoerper, SSX antikoerper, SSX2 antikoerper, SSX3 antikoerper, SSX family member 2 antikoerper, protein SSX2 antikoerper, synovial sarcoma, X breakpoint 2 antikoerper, SSX2 antikoerper, LOC741661 antikoerper, Ssx2 antikoerper

Hintergrund: SSX2 belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t(X,18) translocation characteristically found in all synovial sarcomas. This translocation results in the fusion of the synovial sarcoma translocation gene on chromosome 18 to one of the SSX genes on chromosome X. The encoded hybrid proteins are probably responsible for transforming activity. Two transcript variants encoding distinct isoforms have been identified for this gene. Synonyms: Polyclonal SSX2 antibody, Anti-SSX2 antibody, synovial sarcoma, X breakpoint 2 antibody, HD21 antibody, HOM-MEL-40 antibody, MGC119055 antibody, MGC15364 antibody, MGC3884 antibody, SSX antibody.